SCOPUS 정보 검색 플랫폼

Volumn 33, Issue 2, 2009, Pages 44-46

Going green in oharmaceuticals

a Pharmaceutical Technology (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DARUNAVIR; LY 686017; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; NEUROKININ 1 RECEPTOR ANTAGONIST; NORSERTRALINE; PYRIDINYLIMADAZOLE; RALTEGRAVIR; UNCLASSIFIED DRUG;

BIOCATALYSIS; CATALYSIS; DRUG MANUFACTURE; PHARMACEUTICS; SHORT SURVEY;

EID: 77951855394 PISSN: 15432521 EISSN: None Source Type: Journal
DOI: None Document Type: Short Survey

Times cited : (2)

References (4)

1
- 51849142029
- EPA, Washington, DC, available at, accessed Jan. 15
- EPA, "The Presidential Green Chemistry Challenge Awards Program: Summary of 2008 Award Entries and Recipients" (Washington, DC, 2008), available at www.epa.gov/greenchemistry/pubs/docs/award-entries-and- recipients2008.pdf, accessed Jan. 15, 2009.
- (2008) The Presidential Green Chemistry Challenge Awards Program: Summary of 2008 Award Entries and Recipients

2
- 36348937198
- The E factor: Fifteen years on
- R. A. Sheldon, "The E Factor: Fifteen Years On, " Green Chem. 9 (12), 1273-1283 (2007).
- (2007) Green Chem. , vol.9 , Issue.12 , pp. 1273-1283
- Sheldon, R.A.¹

3
- 77951804312
- presented at The 12th Annual Green Chemistry and Engineering Conference, New York, June 25
- M. E. Kopach, "A Practical and Green Chemical Approach for the Manufacture of NK1 Antagonist LY686017, " presented at The 12th Annual Green Chemistry and Engineering Conference, New York, June 25, 2008.
- A Practical and Green Chemical Approach for the Manufacture of NK1 Antagonist LY686017 , pp. 2008
- Kopach, M.E.¹

4
- 34748881846
- Advances in asymmetric synthesis
- P. Van Arnum, "Advances in Asymmetric Synthesis, " Pharm. Technol. 31 (9), 58-65 (2007).
- (2007) Pharm. Technol. , vol.31 , Issue.9 , pp. 58-65
- Van Arnum, P.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.